Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Female Breast Carcinoma
Interventions: DRUG: anastrozole|DRUG: Palbociclib
Sponsor: Wake Forest University Health Sciences
Collaborators: Pfizer|Atrium Health Levine Cancer Institute